Navigation Links
Curemark Moderates Autism Panel at Life Sciences Summit 2010
Date:10/11/2010

Young, PhD, William P. Timmie professor of psychiatry, Emory University School of Medicine.  

Although most research efforts have focused on determining the genetic underpinnings of ASD, the panel discussed progress in understanding the neurochemicals believed to contribute to the pathology and symptoms of the disease.  These neurochemicals present nearer-term opportunities to repurpose existing therapeutics for use in treating some of the symptoms of ASD, the panel noted.  Panelists discussed several currently marketed products that are in development to address aggression/irritability, repetitive behavior and social impairment.  Additional research is focused on inflammatory and immune processes that may be associated with the pathogenesis of autism, such as research findings emerging from human genetic and animal studies which suggest that disruption of a key developmental process related to synapses may be a factor, the panel said.

Curemark's autism treatment targets enzyme deficiencies in autistic children which affect the availability of amino acids, the building blocks of chemicals essential for brain function.  If approved, it will be one of the first therapies to address the underlying physiology of autism.          

About CUREMARK LLC

Curemark is a drug research and development company focused on the treatment of neurological and other diseases, especially those with dysautonomic components, by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon, which revealed a lack of protein digestion in children with autism and ADHD. To learn more about our innovative science, visit www.curemark.com

Safe Harbor Statement

This news release contains forward-looking statements that involve risks and
'/>"/>

SOURCE Curemark LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Curemark Presents at the Rodman & Renshaw Annual Global Investment Conference
2. James F. Szigethy Named Curemarks Director of New Product Development
3. Curemark to Present at BioPharm America™ 2010
4. Curemark to Present at the Rodman & Renshaw Annual Global Investment Conference
5. Curemark Opens Autism Trials at New Jersey Site
6. Curemark Begins Autism Trials at Two More Sites
7. Dr. Joan Fallon, Curemark CEO, Addresses Keystone Symposia Meeting On Autism
8. Curemark Adds UC Davis MIND Institute to Autism Clinical Trial Sites
9. Curemark CM-AT Autism Treatment Granted FDA Fast Track Status
10. Curemark Enrolling Patients In Phase III Autism Trials At Ten Sites
11. Curemark Opens Patient Enrollment for Autism Treatment at Three More Clinical Trial Sites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)...   Headquartered in Anaheim, California ... diversified company.  WholeHEALTH Products Inc. is focused on leveraging ... proven expertise of its team of professionals to ... WholeHEALTH Products, comprehensive line of 22 professional diagnostic ... and 8 retail consumer tests is your partner ...
(Date:11/18/2014)... 2014  Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... European Commission (the "EC") to extend the deadline for ... by a limited number of days in order to ... Deadline extensions are not uncommon in such in-depth ... authorities to facilitate their review of the pending transaction ...
(Date:11/18/2014)... , Nov. 18, 2014  Cardica, Inc. ... the Cardica Board has approved management,s recommendation to ... launch of the MicroCutter XCHANGE® 30 surgical stapler ... commercial launch.  As a result, Cardica has temporarily ... withdrawing its latest iteration of the MicroCutter XCHANGE ...
Breaking Medicine Technology:WholeHEALTH Product Inc. to File FDA Emergency Use Approval (EUA) for PCR Rapid Ebola Test 2Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 2Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 3Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 4Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 5Cardica Announces Shift In Focus 2Cardica Announces Shift In Focus 3
... , CRANBURY, N.J. , Feb. 9 ... announced the completion of first cohort dosing in a placebo-controlled, ... dysfunction.  The primary endpoint in this double-blind safety study is ... between 45 and 65 years old.  The study will also ...
... , SAN MATEO, Calif. , ... the leader in high quality 3D Cone Beam Imaging systems for ... as Director of Marketing. , PreXion President/COO Robert Meier ... management team and I look forward to working with him in ...
Cached Medicine Technology:Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 2Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 3Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 4PreXion, Inc. Announces Appointment of Director of Marketing 2
(Date:11/17/2014)... A Diet Doc in-house clinical study ... are turning back the clock on aging, looking younger ... the company has recently added their prescription anti-aging human ... prescription and non-prescription diet products and healthy living supplements. ... best anti-aging human growth hormone therapy to their ...
(Date:11/17/2014)... Oskaloosa, IA (PRWEB) November 17, 2014 ... featured in an upcoming episode of American Farmer airing ... Tuesday at 8:30 am ET on RFD-TV. , World ... organic plant based proteins. World Food’s unique system provides ... seed to protein ingredients. , This segment will educate ...
(Date:11/17/2014)... (PRWEB) November 17, 2014 QuickChek customers ... their September “Dog Tag” Promotion. In total, ... Hope For The Warriors® in support of military families ... is a national nonprofit dedicated to restoring a sense ... for our service members and our military families. ...
(Date:11/17/2014)... (PRWEB) November 17, 2014 For the ... specialist used DNA sequencing from a single cell extracted ... that ran in the father’s family. Double-board certified expert ... Springs and Newport Beach, then implanted only the healthy ... , “The world of In Vitro Fertilization has taken ...
(Date:11/17/2014)... (PRWEB) November 17, 2014 Wright & ... Miami ordered Boston Scientific Corp. to pay a total ... who filed bladder mesh lawsuits after they suffered injuries ... company’s Pinnacle transvaginal mesh implant. Bloomberg reported that jurors ... defectively designed and the company failed to warn physicians ...
Breaking Medicine News(10 mins):Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 2Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 3Health News:American Farmer to Feature World Food Processing in 2015 Series 2Health News:QuickChek Gives Big Support to Hope For The Warriors One Dollar at a Time 2Health News:IVF Specialist From American Reproductive Centers Performs World's First DNA Sequencing On Single Cell So Defected Genes Won't Be Passed To Future Generations 2Health News:Boston Scientific Ordered To Pay $28.7 Million In Bladder Mesh Lawsuits After Injuries From Pelvic Mesh Implant Reports Wright & Schulte LLC 2Health News:Boston Scientific Ordered To Pay $28.7 Million In Bladder Mesh Lawsuits After Injuries From Pelvic Mesh Implant Reports Wright & Schulte LLC 3Health News:Boston Scientific Ordered To Pay $28.7 Million In Bladder Mesh Lawsuits After Injuries From Pelvic Mesh Implant Reports Wright & Schulte LLC 4
... Feb. 1 (HealthDay News) -- Among injection drug users, new ... two decades, but the number of new infections from the ... new study reports. The findings suggest that efforts -- ... to prevent blood-borne transmission of infectious diseases have been successful ...
... February 1, 2011 While the overall death rate for ... to have higher death rates and shorter survival of any ... The findings come from Cancer Facts & Figures for African ... two years by the American Cancer Society. The higher ...
... circulating DNA may indicate faster progression of lung cancer ... in the February edition of the Journal of ... Association for the Study of Lung Cancer (IASLC). ... presented more free DNA in the blood than healthy ...
... , MONDAY, Jan. 31 (HealthDay News) -- X-rays, CT scans ... back pain, but often these tests are unnecessary, suggests new ... more, these imaging tests have the potential to cause harm ... -- such as a bulging disc -- that may not ...
... Steven Reinberg HealthDay Reporter , MONDAY, Jan. 31 ... having a stroke, they appear to have better odds of ... This finding might seem odd since conventional wisdom says black ... medical care in general. However, the same trend has been ...
... services that supports California,s low-income, disabled elderly is fragile, ... independent lives in their own homes, according to a ... Research. This policy note reports the ... lives and challenges encountered by several dozen representative older ...
Cached Medicine News:Health News:Infectious Disease Experts Call for More Focus on Hepatitis C 2Health News:Race gap narrows for some cancers in African-Americans; continues to increase for others 2Health News:Race gap narrows for some cancers in African-Americans; continues to increase for others 3Health News:High levels of circulating DNA may signal faster progression of lung cancer 2Health News:Most X-Rays, Scans Unnecessary for Acute Low Back Pain 2Health News:Most X-Rays, Scans Unnecessary for Acute Low Back Pain 3Health News:Survival After Stroke Better for Blacks 2Health News:Survival After Stroke Better for Blacks 3Health News:Aging safely at home? California's disabled elderly are barely holding on 2Health News:Aging safely at home? California's disabled elderly are barely holding on 3
... The BD Macro-Vue RPR (Rapid ... and Tear-drop Tests are nontreponemal testing ... syphilis described in A Manual of ... in this manual are the most ...
... For use as a non-reactive quality assurance reagent ... Toxoplasma gondii (TOXO IgG and TOXO IgM), IgG ... and rubella IgM), IgG and IgM antibodies to ... IgM antibodies to herpes simplex virus types 1 ...
... is the third diagnostic,hepatitis assay approved by ... being run in a random,access format on ... the laboratory staff,can run an anti-HCV test ... 27 assays, and provide anti-HCV,test results in ...
... a non-reactive quality assurance reagent in assays ... 1 (anti-HIV-1), antibody to human immunodeficiency virus ... virus type 1 (HIV-1 Ag), antibody to ... to hepatitis C virus (anti-HCV), immunoglobulin M ...
Medicine Products: